The NC Division of Public Health announced Tuesday that it was contacting 132 health care providers who received H1N1 pediatric vaccine from four lots that were voluntarily recalled by the manufacturer, Sanofi Pasteur. The state received 17,900 doses from the approximately 800,000 doses impacted by the recall. “There are no safety concerns with these lots of H1N1 vaccine,” State Epidemiologist Megan Davies, MD, said. “The concern is that the recalled vaccine may not be strong enough to provide full immunity.” Sanofi Pasteur determined that the antigen content, which is the component in the vaccine that causes immunity to a virus, is slightly below the specified range. The CDC says the vaccine in these lots still offers protection against H1N1 influenza. The CDC does not recommend doctors re-administer flu shots to those who received vaccine from these lots. More information is available on the voluntary recall at: http://www.cdc.gov/h1n1flu/vaccination/syringes_qa.htm.
